Have you got a query?

Share prices for NVM’s funds are published daily in the London Stock Exchange share price listing pages in the Financial Times - look under the “Investment Companies - Conventional Trusts and VCTs” heading. If you are an internet user, you can access a link to almost-live share price data from the London Stock Exchange. Click on the relevant link below to view the fund share price:

Alternatively, you can call NVM’s Newcastle office and ask for a share price update over the telephone.

Shareholdings (ie number of shares held) can be confirmed by our share registrars, Equiniti Limited - contact details are shown below. The registrars will ask you to confirm (i) the name of the NVM fund in which you hold shares and (ii) your full name and address. Financial advisers should note that the registrars are not permitted to disclose shareholder information to third parties without written authority from the shareholder.

Changes to personal details (name, address etc.) of shareholders should be notified as soon as possible in writing, and signed by the shareholders, to Equiniti Limited. Please note that for legal reasons, and for the protection of shareholders, such notifications cannot be given by telephone or by e-mail.

All other queries should in the first instance be directed to Wendy Arkle who can be contacted by telephone on 0191 244 6024, by e-mail at wendy.arkle@nvm.co.uk or by post at NVM’s Newcastle office. Alternatively you can submit an information request form.

Our registrar’s contact details are as follows:

Equiniti Limited
Aspect House
Spencer Road
LANCING
BN99 6DA
Shareholder Helpline: 0871 384 2030

Latest news

VCT for income: Northern 3 VCT 15 million share issue offer

Northern 3 VCT PLC has launched a public offer of 15 million new ordinary shares. For further information & the prospectus click here.

Abermed sold to
International SOS

NVM has sold its investment in Abermed, the UK occupational health and remote medical services company, to International SOS, the world's leading provider of integrated medical and security assistance, for an undisclosed consideration. For further information click here.

DxS sold to Qiagen –
record exit for NVM

NVM has sold DxS to Qiagen to create a global leader in personalised medicine for a value of $130 million ($95 million initial consideration plus earnouts of up to $35 million). For further information click here.